INTRODUCTION: Meningioma frequently recur at the primary resection site requiring improvement in the intraoperative tumor visualization and surgical technique. To guide the resection, this study aims to develop a highly specific and sensitive optical method for intraoperative meningioma imaging. By suitable cameras fluorescent dyes in the near infrared (NIR, 700-1000nm) can be detected up to few millimeters in depth in real time. METHODS: We invented a SSTR2 targeting probe by linking a somatostatin analogue (TATE, Tyr(3)Thr(8)-Octreotid) to a new developed dye (sNIR). In the optical characterization, our probe showed similarities to indocyanine green and stability as well as bleaching kinetic were investigated in vitro. The probe was intravenously injected in native mice and detected by a custom-built camera setup to evaluate pharmacokinetics and biodistribution, focusing on physiologically SSTR2 overexpressing organs that were validated by immunohistochemistry (IHC). As proof-of-principle, fluorescence-guided meningioma resection was performed in an ectopic and orthotopic IOMM-Lee mouse model. RESULTS: Our probe is stable in aqueous solution up to 12h with favorable optical properties regarding pharmacokinetics, biodistribution and photostability compared to its IRDye800 analogue. In vivo, we observed a highly specific signal uptake in the gastric epithelium, pancreas and pituitary (all are overexpressing SSTR2) compared to autofluorescence and negative controls. Given the intermediate SSTR2 expression in the meningioma mouse model, we could still detect a mean tumor-to-brain ratio of 6.12 (n = 5; SD 1.8) allowing the fluorescence-guidance to be feasible. CONCLUSIONS: Our preclinical results indicate that the new SSTR2-targeted fluorescent probe is stable in various media over time and capable of specifically targeting the SSTR2 in vitro and in vivo potentially enabling sensitive and specific meningioma fluorescent-guided surgery in the future.
Read full abstract